Sandbox ammu: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
===Bronchiolitis===
===Bronchiolitis===
'''Treatment'''
:* Preferred regimen:  
:* Preferred regimen:  
::: Note
:: Note
 
::* Clinicians should administer nasogastric or intravenous fluids for infants with a diagnosis of bronchiolitis who cannot maintain hydration orally
::* Clinicians should not administer albuterol (or salbutamol) to infants and children with a diagnosis of bronchiolitis.
::* Clinicians should not administer epinephrine to infants and children with a diagnosis of bronchiolitis.
::* Clinicians should not administer systemic corticosteroids to infants with a diagnosis of bronchiolitis in any setting.
::* Clinicians should not administer antibacterial medications to infants and children with a diagnosis of bronchiolitis unless there is a concomitant bacterial infection, or a strong suspicion of one.
'''Prophylaxis'''
:* Preferred regimen:
:: Note
::* Clinicians should not administer palivizumab to otherwise healthy infants with a gestational age of 29 weeks, 0 days or greater.
::* All people should disinfect hands before and after direct contact with patients, after contact with inanimate objects in the direct vicinity of the patient, and after removing gloves.
::* All people should use alcoholbased rubs for hand decontamination when caring for children with bronchiolitis. When alcoholbased rubs are not available, individuals should wash their hands with soap and water.
::*  Clinicians should counsel caregivers about exposing the infant or child to environmental tobacco smoke and smoking cessation when assessing a child for bronchiolitis.

Revision as of 18:52, 16 June 2015

Bronchiolitis

Treatment

  • Preferred regimen:
Note
  • Clinicians should administer nasogastric or intravenous fluids for infants with a diagnosis of bronchiolitis who cannot maintain hydration orally
  • Clinicians should not administer albuterol (or salbutamol) to infants and children with a diagnosis of bronchiolitis.
  • Clinicians should not administer epinephrine to infants and children with a diagnosis of bronchiolitis.
  • Clinicians should not administer systemic corticosteroids to infants with a diagnosis of bronchiolitis in any setting.
  • Clinicians should not administer antibacterial medications to infants and children with a diagnosis of bronchiolitis unless there is a concomitant bacterial infection, or a strong suspicion of one.

Prophylaxis

  • Preferred regimen:
Note
  • Clinicians should not administer palivizumab to otherwise healthy infants with a gestational age of 29 weeks, 0 days or greater.
  • All people should disinfect hands before and after direct contact with patients, after contact with inanimate objects in the direct vicinity of the patient, and after removing gloves.
  • All people should use alcoholbased rubs for hand decontamination when caring for children with bronchiolitis. When alcoholbased rubs are not available, individuals should wash their hands with soap and water.
  • Clinicians should counsel caregivers about exposing the infant or child to environmental tobacco smoke and smoking cessation when assessing a child for bronchiolitis.